[
  {
    "title": "1 Value Stock with Solid Fundamentals and 2 to Turn Down",
    "published": 1742821322,
    "posting_price": 92.90000153,
    "close_price": 91.83999634,
    "percent_change": -1.14101741
  },
  {
    "title": "3 of Goldman Sachs' best investing tips for currently volatile markets",
    "published": 1742563852,
    "posting_price": 94.58000183,
    "close_price": 93.11000061,
    "percent_change": -1.55424106
  },
  {
    "title": "Merck (NYSE:MRK) Unveils New Data On Cardiovascular Advances At ACC.25 Annual Conference",
    "published": 1742491921,
    "posting_price": 94.0,
    "close_price": 94.73000336,
    "percent_change": 0.77659932
  },
  {
    "title": "Merck Loses Almost $52B in 6 Months: How to Play MRK Stock",
    "published": 1742393460,
    "posting_price": 95.25,
    "close_price": 94.01999664,
    "percent_change": -1.29134211
  },
  {
    "title": "Actinium Pharmaceuticals launches clinical trial for Actimab-A in combination",
    "published": 1742386292,
    "posting_price": 95.25,
    "close_price": 94.01999664,
    "percent_change": -1.29134211
  },
  {
    "title": "Health Canada Approves KEYTRUDA\u00ae for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy",
    "published": 1742382000,
    "posting_price": 95.25,
    "close_price": 94.01999664,
    "percent_change": -1.29134211
  },
  {
    "title": "Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease",
    "published": 1742381100,
    "posting_price": 95.25,
    "close_price": 94.01999664,
    "percent_change": -1.29134211
  },
  {
    "title": "Is Merck & Co Inc. (NYSE:MRK) the Most Undervalued S&P 500 Stock to Buy Now?",
    "published": 1742302016,
    "posting_price": 95.23000336,
    "close_price": 94.72000122,
    "percent_change": -0.53554775
  },
  {
    "title": "Is Merck & Co Inc. (NYSE:MRK) the Most Profitable Value Stock to Buy Now?",
    "published": 1742239948,
    "posting_price": 93.65000153,
    "close_price": 94.79000092,
    "percent_change": 1.21729778
  },
  {
    "title": "MSD to push for approval of HIV combo after Phase III success",
    "published": 1741870187,
    "posting_price": 92.60002634,
    "close_price": 93.89880371,
    "percent_change": 1.40256696
  },
  {
    "title": "Merck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025",
    "published": 1741800637,
    "posting_price": 93.26427989,
    "close_price": 92.55044556,
    "percent_change": -0.76538878
  },
  {
    "title": "Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) Maintained HIV-1 Viral Suppression at Week 48",
    "published": 1741793160,
    "posting_price": 93.26427989,
    "close_price": 92.55044556,
    "percent_change": -0.76538878
  },
  {
    "title": "10 Best Low Volatility ETFs To Buy",
    "published": 1713181738,
    "posting_price": 123.04320934,
    "close_price": 122.55760193,
    "percent_change": -0.39466413
  },
  {
    "title": "Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead",
    "published": 1713174360,
    "posting_price": 123.04320934,
    "close_price": 122.55760193,
    "percent_change": -0.39466413
  },
  {
    "title": "7 A-Rated Aggressive Biotech Stocks to Bet On in 2024",
    "published": 1712918400,
    "posting_price": 123.38312661,
    "close_price": 122.12054443,
    "percent_change": -1.02330214
  },
  {
    "title": "Biogen Is Suffering From Doubts About the Future",
    "published": 1712908860,
    "posting_price": 123.38312661,
    "close_price": 122.12054443,
    "percent_change": -1.02330214
  },
  {
    "title": "GLOBAL BROKER RATINGS: JPMorgan raises Persimmon, BoA raises Nike",
    "published": 1712906940,
    "posting_price": 123.38312661,
    "close_price": 122.12054443,
    "percent_change": -1.02330214
  },
  {
    "title": "Merck & Company: Balancing Growth Prospects Against Rising Operational Challenges",
    "published": 1712894820,
    "posting_price": 123.38312661,
    "close_price": 122.12054443,
    "percent_change": -1.02330214
  },
  {
    "title": "Merck & Co., Inc.'s (NYSE:MRK) Stock Financial Prospects Look Bleak: Should Shareholders Be Prepared For A Share Price Correction?",
    "published": 1712844048,
    "posting_price": 122.90723281,
    "close_price": 122.51874542,
    "percent_change": -0.3160818
  },
  {
    "title": "Declining COVID-19 Vaccine Sales Pinches Moderna, Pauses Kenya Vaccine Plant Plans",
    "published": 1712831100,
    "posting_price": 122.90723281,
    "close_price": 122.51874542,
    "percent_change": -0.3160818
  },
  {
    "title": "Cardinal Health, Cigna, Merck among top healthcare Quant picks ahead of Q1 earnings",
    "published": 1712828340,
    "posting_price": 122.90723281,
    "close_price": 122.51874542,
    "percent_change": -0.3160818
  },
  {
    "title": "The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today",
    "published": 1712825520,
    "posting_price": 122.90723281,
    "close_price": 122.51874542,
    "percent_change": -0.3160818
  },
  {
    "title": "See Which Of The Latest 13F Filers Holds Merck & Co",
    "published": 1712799300,
    "posting_price": 122.90723281,
    "close_price": 122.51874542,
    "percent_change": -0.3160818
  },
  {
    "title": "Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study",
    "published": 1712761140,
    "posting_price": 122.23709798,
    "close_price": 123.10147858,
    "percent_change": 0.70713443
  },
  {
    "title": "Company News for Apr 10, 2024",
    "published": 1712755500,
    "posting_price": 122.23709798,
    "close_price": 123.10147858,
    "percent_change": 0.70713443
  },
  {
    "title": "MRK December 2026 Options Begin Trading",
    "published": 1712743860,
    "posting_price": 122.23709798,
    "close_price": 123.10147858,
    "percent_change": 0.70713443
  },
  {
    "title": "The Pharmaceutical Industry Finds Itself At A Historical Crossroads",
    "published": 1712742780,
    "posting_price": 122.23709798,
    "close_price": 123.10147858,
    "percent_change": 0.70713443
  },
  {
    "title": "Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says",
    "published": 1712713620,
    "posting_price": 122.23709798,
    "close_price": 123.10147858,
    "percent_change": 0.70713443
  },
  {
    "title": "Moderna stock climbs 8% amid head/neck cancer vaccine data",
    "published": 1712658480,
    "posting_price": 122.93637444,
    "close_price": 123.0626297,
    "percent_change": 0.10269968
  },
  {
    "title": "Upcoming Catalysts Position Perrigo For Sustained Long-Term Dividend Growth",
    "published": 1712641773,
    "posting_price": 122.93637444,
    "close_price": 123.0626297,
    "percent_change": 0.10269968
  },
  {
    "title": "Golden Years Gainers: 3 Stocks to Fund Your Dream Retirement",
    "published": 1712599200,
    "posting_price": 123.96585251,
    "close_price": 122.91693878,
    "percent_change": -0.84613118
  },
  {
    "title": "Merck price target raised by $3 at Berenberg, here's why",
    "published": 1712567220,
    "posting_price": 123.96585251,
    "close_price": 122.91693878,
    "percent_change": -0.84613118
  },
  {
    "title": "Merck price target raised to $146 from $140 at Berenberg",
    "published": 1712551380,
    "posting_price": 123.96585251,
    "close_price": 122.91693878,
    "percent_change": -0.84613118
  },
  {
    "title": "Moderna Stock (NASDAQ:MRNA): This mRNA Tech Pioneer Has Rebound Potential",
    "published": 1712540580,
    "posting_price": 123.96585251,
    "close_price": 122.91693878,
    "percent_change": -0.84613118
  },
  {
    "title": "The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024",
    "published": 1712512800
  },
  {
    "title": "Morgan Stanley sees Fed rate cut fueling biotech stocks",
    "published": 1712493540
  },
  {
    "title": "Morgan Stanley sees Fed rate cut fueling biotech stock performance",
    "published": 1712493180
  },
  {
    "title": "Citi's top recommended large-cap stocks",
    "published": 1712452440
  },
  {
    "title": "10 Best Weight Loss Drug Stocks to Buy Now",
    "published": 1712450873
  },
  {
    "title": "The three-year decline in earnings for Merck NYSE:MRK) isn't encouraging, but shareholders are still up 93% over that period",
    "published": 1712408476
  },
  {
    "title": "Merck (MRK) Rises Yet Lags Behind Market: Some Facts Worth Knowing",
    "published": 1712353519,
    "posting_price": 123.97556142,
    "close_price": 124.30577087,
    "percent_change": 0.26635044
  },
  {
    "title": "BME: Trading At A Historical Discount To NAV",
    "published": 1712317631,
    "posting_price": 123.97556142,
    "close_price": 124.30577087,
    "percent_change": 0.26635044
  },
  {
    "title": "Merck & Company (MRK) Receives a Buy from Cantor Fitzgerald",
    "published": 1712315760,
    "posting_price": 123.97556142,
    "close_price": 124.30577087,
    "percent_change": 0.26635044
  },
  {
    "title": "Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA for First-Line Treatment of Certain Patients with Metastatic Non-Small Cell Lung Cancer",
    "published": 1712311010,
    "posting_price": 123.97556142,
    "close_price": 124.30577087,
    "percent_change": 0.26635044
  },
  {
    "title": "10 Health Care Stocks Whale Activity In Today's Session",
    "published": 1712234280,
    "posting_price": 127.06403199,
    "close_price": 123.9852829,
    "percent_change": -2.42299024
  },
  {
    "title": "Merck puts KRAS cancer drug competitor to the test",
    "published": 1712230680,
    "posting_price": 127.06403199,
    "close_price": 123.9852829,
    "percent_change": -2.42299024
  },
  {
    "title": "Piper Sandler pharmaceuticals analysts hold an analyst/industry conference call",
    "published": 1712229060,
    "posting_price": 127.06403199,
    "close_price": 123.9852829,
    "percent_change": -2.42299024
  },
  {
    "title": "Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA\u00ae (pembrolizumab) for First-Line Treatment of Certain Patients With Metastatic Non-Small Cell Lung Cancer",
    "published": 1712227500,
    "posting_price": 127.06403199,
    "close_price": 123.9852829,
    "percent_change": -2.42299024
  },
  {
    "title": "Merck: launches phase III trial in lung cancer",
    "published": 1712219581,
    "posting_price": 127.06403199,
    "close_price": 123.9852829,
    "percent_change": -2.42299024
  },
  {
    "title": "Merck to test lung cancer combo therapy in late-stage trial",
    "published": 1712215920,
    "posting_price": 127.06403199,
    "close_price": 123.9852829,
    "percent_change": -2.42299024
  },
  {
    "title": "Merck starts phase 3 MK-1084 trial for lung cancer treatment",
    "published": 1712215800,
    "posting_price": 127.06403199,
    "close_price": 123.9852829,
    "percent_change": -2.42299024
  },
  {
    "title": "Merck initiates Phase 3 clinical trial of MK-1084",
    "published": 1712209740,
    "posting_price": 127.06403199,
    "close_price": 123.9852829,
    "percent_change": -2.42299024
  },
  {
    "title": "Merck (MRK) Stock Sinks As Market Gains: What You Should Know",
    "published": 1712181019,
    "posting_price": 126.59785564,
    "close_price": 126.16079712,
    "percent_change": -0.34523375
  },
  {
    "title": "3 Dow Jones Stocks For Your April 2024 Watch List",
    "published": 1712154826,
    "posting_price": 126.59785564,
    "close_price": 126.16079712,
    "percent_change": -0.34523375
  },
  {
    "title": "Bristol Myers wins label expansion for anemia therapy in EU",
    "published": 1712146200,
    "posting_price": 126.59785564,
    "close_price": 126.16079712,
    "percent_change": -0.34523375
  },
  {
    "title": "REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan Initiated in Patients with Platinum-Resistant Ovarian Cancer",
    "published": 1712145600,
    "posting_price": 126.59785564,
    "close_price": 126.16079712,
    "percent_change": -0.34523375
  },
  {
    "title": "Daiichi, Merck announce first patient dosed in ovarian cancer trial",
    "published": 1712139180,
    "posting_price": 126.59785564,
    "close_price": 126.16079712,
    "percent_change": -0.34523375
  },
  {
    "title": "Merck: 1st patient in raludotatug study",
    "published": 1712137346,
    "posting_price": 126.59785564,
    "close_price": 126.16079712,
    "percent_change": -0.34523375
  },
  {
    "title": "Merck: We Were Wrong, But The Exuberance Is Overly Done Here (Rating Upgrade)",
    "published": 1712134800,
    "posting_price": 126.59785564,
    "close_price": 126.16079712,
    "percent_change": -0.34523375
  },
  {
    "title": "Daiichi Sankyo, Merck announe first patient dosed in REJOICE-Ovarian01 trial",
    "published": 1712128320,
    "posting_price": 126.59785564,
    "close_price": 126.16079712,
    "percent_change": -0.34523375
  },
  {
    "title": "Market Whales and Their Recent Bets on MRK Options",
    "published": 1712116260,
    "posting_price": 126.59785564,
    "close_price": 126.16079712,
    "percent_change": -0.34523375
  },
  {
    "title": "Merck: Better Times Ahead On Approvals And Outlook",
    "published": 1712075977,
    "posting_price": 126.3550433,
    "close_price": 126.59784698,
    "percent_change": 0.19215986
  },
  {
    "title": "Cantor Fitzgerald Remains a Buy on Merck & Company (MRK)",
    "published": 1712028360,
    "posting_price": 126.3550433,
    "close_price": 126.59784698,
    "percent_change": 0.19215986
  },
  {
    "title": "Russell 2000 Index Best And Worst Performing Stocks Of 2024",
    "published": 1712020200,
    "posting_price": 126.3550433,
    "close_price": 126.59784698,
    "percent_change": 0.19215986
  },
  {
    "title": "Why Merck (MRK) is a Top Momentum Stock for the Long-Term",
    "published": 1711979411,
    "posting_price": 127.88955476,
    "close_price": 127.21942902,
    "percent_change": -0.52398786
  },
  {
    "title": "Merck to Hold First-Quarter 2024 Sales and Earnings Conference Call April 25",
    "published": 1711968300,
    "posting_price": 127.88955476,
    "close_price": 127.21942902,
    "percent_change": -0.52398786
  },
  {
    "title": "The least shorted S&P 500 stocks as a percentage of float - BofA",
    "published": 1711964940,
    "posting_price": 127.88955476,
    "close_price": 127.21942902,
    "percent_change": -0.52398786
  },
  {
    "title": "Expert Ratings For Merck & Co",
    "published": 1711958700,
    "posting_price": 127.88955476,
    "close_price": 127.21942902,
    "percent_change": -0.52398786
  },
  {
    "title": "Merck & Co. Inc. stock underperforms Monday when compared to competitors",
    "published": 1711942560,
    "posting_price": 127.88955476,
    "close_price": 127.21942902,
    "percent_change": -0.52398786
  }
]